| pubmed-article:20186279 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20186279 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:20186279 | lifeskim:mentions | umls-concept:C0032143 | lld:lifeskim |
| pubmed-article:20186279 | lifeskim:mentions | umls-concept:C0042903 | lld:lifeskim |
| pubmed-article:20186279 | lifeskim:mentions | umls-concept:C0242383 | lld:lifeskim |
| pubmed-article:20186279 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
| pubmed-article:20186279 | lifeskim:mentions | umls-concept:C0017110 | lld:lifeskim |
| pubmed-article:20186279 | lifeskim:mentions | umls-concept:C0333275 | lld:lifeskim |
| pubmed-article:20186279 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:20186279 | lifeskim:mentions | umls-concept:C1517572 | lld:lifeskim |
| pubmed-article:20186279 | lifeskim:mentions | umls-concept:C1656863 | lld:lifeskim |
| pubmed-article:20186279 | pubmed:dateCreated | 2010-2-26 | lld:pubmed |
| pubmed-article:20186279 | pubmed:abstractText | To determine the efficacy and safety of treating predominantly hemorrhagic age-related macular degeneration (AMD) with transconjunctival sutureless vitrectomy (TSV), tissue plasminogen activator (tPA), sulphur hexafluoride (SF6), and intravitreal bevacizumab. | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20186279 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20186279 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:20186279 | pubmed:issn | 1177-5483 | lld:pubmed |
| pubmed-article:20186279 | pubmed:author | pubmed-author:AriasLuisL | lld:pubmed |
| pubmed-article:20186279 | pubmed:author | pubmed-author:MonésJordiJ | lld:pubmed |
| pubmed-article:20186279 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20186279 | pubmed:volume | 4 | lld:pubmed |
| pubmed-article:20186279 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20186279 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20186279 | pubmed:pagination | 67-72 | lld:pubmed |
| pubmed-article:20186279 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20186279 | pubmed:articleTitle | Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration. | lld:pubmed |
| pubmed-article:20186279 | pubmed:affiliation | Institut de la Màcula i de la Retina, Department of Ophthalmology, Hospital Universitari de Bellvitge, Centro Médico Teknon, Barcelona. luisarias@telefonica.net | lld:pubmed |
| pubmed-article:20186279 | pubmed:publicationType | Journal Article | lld:pubmed |
